Los Angeles Allergist

Los Angeles Allergist

Alan Khadavi, MD, APC
  • Home
  • Meet Dr. Khadavi
  • Conditions We Treat
  • Your First Visit
  • Insurance Accepted
  • Allergy and Asthma Info
    • Asthma Info
    • Allergic Rhinitis
    • Allergic Triggers
  • Blog
  • Media
  • Contact Us

9001 Wilshire Blvd. Suite 204
Beverly Hills, CA 90211
Phone: 310-282-8822

15450 Ventura Blvd. Suite 102
Sherman Oaks, CA 91403
Phone: 818-528-7776

February 21, 2018 by Alan Khadavi

Xhance for Nasal Polyps

xhance

Xhance is a new nasal spray to be available April 2018.  Xhance is indicated for the the treatment of nasal polyps in patients 18 years or older.  The active ingredient in Xhance is fluticasone propionate 93 mcg.  If that sounds familiar, fluticasone propionate is the active ingredient in Flonase.  What is different from Xhance from […]

Filed Under: Blog, Medications

February 15, 2018 by Alan Khadavi

PR022 for Atopic Dermatitis (Eczema)

pr022

PR022 is a new topical gel being studied for the treatment of atopic dermatitis.  It is entering Phase 2 trials and it is being manufactured by Realm Therapeutics.  Data is supposed to come out in the 3rd quarter of 2018. PR022 consists of hypochlorous acid (HOCL).  HOCL is an ideal wound care agent with powerful […]

Filed Under: atopic dermatitis, Blog

February 14, 2018 by Alan Khadavi

AllergyLosAngeles.com named top Allergy Blog Again

allergy blog

Our website was named a top allergy blog by feedspot.com and our blog came in at #8 this year.  It is a great honor to be named one of the top allergy blogs in the world.  Many other blog sites have teams of writers who write for them, but we have just one blogger, Dr. […]

Filed Under: Blog

February 13, 2018 by Alan Khadavi

Dupilumab for Nasal Polyps

utuly

Since the release of dupilumab for atopic dermatitis, studies are currently underway to investigate dupilumab for nasal polyps, asthma and a host of other conditions.  Dupilumab is a human monoclonal antibody against interleukin 4 and 13.  A study published in JAMA titled “Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis […]

Filed Under: biologics, Blog

February 9, 2018 by Alan Khadavi

Pet Allergies and Asthma

oclacitinib

Pet allergies and asthma are big problems in this country.  Pet allergy in the home, notably sensitization to cats and dogs, is a strong predictor of the development of childhood asthma.  More cases of asthma could be attributed to cat allergen than any other sensitization.  Other investigations have shown that there is a protective effect […]

Filed Under: Asthma, Blog, Pet Allergy

January 29, 2018 by Alan Khadavi

Risk Factors for Eosinophilic Esophagitis

eohilia

With the rise of eosinophilic esophagitis being diagnosed in the United States, there likely is a contributing factor.  This is evidenced from twin studies that show stronger disease concordance in twins compared with non twin siblings, suggesting that early-life factors contribute.  Studies have shown that environmental factors account for nearly 85% of the disease cause. […]

Filed Under: Blog, Food allergy, Pediatric

January 23, 2018 by Alan Khadavi

Nucala (mepolizumab) vs. Cinqair (reslizumab)

In a study published in The American Journal of Respiratory Critical Care Medicine, investigators compared intravenous reslizumab (Cinqair) and mepolizumab (Nucala).  Both of them are used for moderate to severe persistent asthma and they both neutralize IL-5, which produces blood eosinophilia and leads to severe eosinophilic asthma. A randomized, placebo controlled trial was used to […]

Filed Under: Asthma, Blog

January 22, 2018 by Alan Khadavi

AR101 a Potential Peanut Allergy Cure

viaskin peanut patch

AR101 is currently being studied by Aimmune Therapeutics to induce desensitization in peanut allergic subjects.  The peanut treatment, AR101, passed through phase 2 trials in 2016, protecting 100% of patients who ate 443 mg of peanuts (1.5 peanuts), 90% of those who ate 1,043 mg (3 peanuts) and 60% who ate 2,043 mg (7 peanuts). A single […]

Filed Under: Anaphylaxis, Blog, Food allergy

January 17, 2018 by Alan Khadavi

Food Diversity and Allergic Disease

best foods for asthma

Food diversity has been a hot topic in allergy since several clinical trials in high-risk children reported that early introduction of highly allergenic foods, especially peanut and egg, prevents food allergy later in life.  This opened up the debate about changing recommendations about the timing of solid food introduction and the length of breast feeding […]

Filed Under: atopic dermatitis, Blog

January 2, 2018 by Alan Khadavi

Allergy to Marijuana

allergy to marijuana

Allergy to marijuana has been on the rise with the legalization of medical marijuana and recreational marijuana in certain states.  Here in California, recreational marijuana has become legalized on January 1st, 2018.  Medical marijuana has been legal for more than 20 years but now with the full legalization in California,  there will be more reactions […]

Filed Under: Blog, Headlines

  • « Previous Page
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 57
  • Next Page »

alan-khadavi
Dr. Alan Khadavi
Allergy & Asthma Specialist

Latest Posts

November 17, 2026

Low Dose Naltrexone for MCAS: Benefits, Risks, and Evidence

LDN for MCAS

November 13, 2026

Cardamom Allergy: Symptoms, Diagnosis, and What to Avoid

cardamom allergy

October 28, 2026

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

October 26, 2026

Which Biologic Works Best for Nasal Polyps?

best biologic for nasal polyps

October 19, 2026

Xolair vs. Omlyclo: Cost, Effectiveness, Insurance & Switching

Xolair vs Omlyclo: Cost, Effectiveness, Insurance & Switching

October 8, 2026

Tapioca Allergy: Can Cassava Cause an Allergic Reaction?

tapioca allergy

October 8, 2026

Rhapsido for Symptomatic Dermographism: An Allergist Explains the New FDA-Approved Treatment

Rhapsido for symptomatic dermographism

October 6, 2026

Most Effective Treatments for Severe Atopic Dermatitis: New Rankings

`most-effective-treatments-severe-atopic-dermatitis

October 6, 2026

Should Airlines Be Required to Carry Epinephrine? An Allergist Explains

airline epinephrine requirement

October 2, 2026

Ketotifen for MCAS: Uses, Benefits, Side Effects, and U.S. Availability

ketotifen for MCAS

Read More Posts...

Follow Us…

© 2026 Allergy Los Angeles. All Rights Reserved · Log in · Return to top of page